Triple therapy of warfarin, aspirin and a thienopyridine for patients treated with vitamin K antagonists undergoing coronary stenting. A review of the evidence

Internal and Emergency Medicine

Volumn 2, Issue 3, 2007, Pages 177-181

  Rubboli, A ^a   Di Pasquale, G ^a  

^a MAGGIORE HOSPITAL   (Italy)

Author keywords

Antiplatelet agents; Oral anticoagulation; Percutaneous coronary intervention; Stent; Vitamin K antagonists; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; PYRIDINE DERIVATIVE; THIENOPYRIDINE; UNCLASSIFIED DRUG; VITAMIN K GROUP; WARFARIN;

DRUG ANTAGONISM; DRUG COMBINATION; HUMAN; REVIEW; STENT; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTICOAGULANTS; ASPIRIN; DRUG THERAPY, COMBINATION; HUMANS; PLATELET AGGREGATION INHIBITORS; PYRIDINES; STENTS; VITAMIN K; WARFARIN;

EID: 35948974252     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-007-0055-5     Document Type: Review

References (11)

1. Popma JJ, Berger P, Ohman EM et al (2004) Antithrombotic therapy during percutaneous coronary intervention. The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126:576S-599S
2. Smith SC Jr, Feldman TE, Hirshfeld JW Jr et al (2006) ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention). Circulation 113:156-175
3. Orford JL, Fasseas P, Melby S et al (2004) Safety and efficacy of aspirin, clopidogrel, and warfarin after coronary stent placement in patients with an indication for anticoagulation. Am Heart J 147:463-467
4. Rubboli A, Colletta M, Sangiorgio P, Di Pasquale G (2004) Antithrombotic strategies in patients with an indication for long-term anticoagulation undergoing coronary artery stenting: safety and efficacy data from a single center. Ital Heart J 5:919-925
5. Mattichack SJ, Reed PS, Gallagher MJ et al (2005) Evaluation of safety of warfarin in combination with antiplatelet therapy for patients treated with coronary stents for acute myocardial infarction. J Interv Cardiol 18:163-166
6. Khurram Z, Chou E, Minutello R et al (2006) Combination therapy with aspirin, clopidogrel and warfarin following coronary stenting is associated with a significant risk of bleeding. J Invasive Cardiol 18:162-164
7. Rubboli A, Colletta M, Sangiorgio P, Di Pasquale G (2004) Antithrombotic treatment after coronary artery stenting in patients on chronic oral anticoagulation: an international survey of current clinical practice. Ital Heart J 5:851-856
8. Fajadet J, Wijns W, Laarman G-J et al (2006) Randomized double-blind, multicenter study of the endeavor zotarolimuseluting phosphorylcholine encapsulated stent for treatment of native coronary artery lesions. Clinical and angiographic results of the ENDEAVOR II trial. Circulation 114:798-806
9. Rubboli A, Milandri M, Castelvetri C, Cosmi B (2005) Metaanalysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting. Cardiology 104:101-106
10. TM: The Antares Study. Cathet Cardiovasc Interv 55:150-156
11. Mehran R, Aymong ED, Ashby DT et al (2003) Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent. Final results of the HOPE (HEPACOAT and an antithrombotic regimen of aspirin alone) Study. Circulation 108:1078-1083